دورية أكاديمية
أعرض في EDS

The Association Between Personal Air Pollution Exposures and Fractional Exhaled Nitric Oxide (FeNO): A Systematic Review.

التفاصيل البيبلوغرافية
العنوان: The Association Between Personal Air Pollution Exposures and Fractional Exhaled Nitric Oxide (FeNO): A Systematic Review.
المؤلفون: Anand A; Department of Public Health Sciences, UConn School of Medicine, UConn Health, 263 Farmington Avenue, Farmington, CT, 06030-6325, USA., Castiglia E; Department of Public Health Sciences, UConn School of Medicine, UConn Health, 263 Farmington Avenue, Farmington, CT, 06030-6325, USA., Zamora ML; Department of Public Health Sciences, UConn School of Medicine, UConn Health, 263 Farmington Avenue, Farmington, CT, 06030-6325, USA. mzamora@uchc.edu.
المصدر: Current environmental health reports [Curr Environ Health Rep] 2024 Jun; Vol. 11 (2), pp. 210-224. Date of Electronic Publication: 2024 Feb 22.
نوع المنشور: Journal Article; Systematic Review; Review; Research Support, N.I.H., Extramural
اللغة: English
بيانات الدورية: Publisher: Springer International Publishing AG Country of Publication: Switzerland NLM ID: 101629387 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2196-5412 (Electronic) Linking ISSN: 21965412 NLM ISO Abbreviation: Curr Environ Health Rep Subsets: MEDLINE
أسماء مطبوعة: Original Publication: [Switzerland] : Springer International Publishing AG, [2014]-
مواضيع طبية MeSH: Nitric Oxide*/analysis , Nitric Oxide*/metabolism , Environmental Exposure*/adverse effects , Environmental Exposure*/analysis , Air Pollution*/adverse effects , Air Pollution*/analysis , Air Pollutants*/analysis , Air Pollutants*/adverse effects, Humans ; Particulate Matter/analysis ; Particulate Matter/adverse effects ; Biomarkers/analysis ; Fractional Exhaled Nitric Oxide Testing/adverse effects ; Exhalation
مستخلص: Purpose of Review: Airway inflammation is a common biological response to many types of environmental exposures and can lead to increased nitric oxide (NO) concentrations in exhaled breath. In recent years, several studies have evaluated airway inflammation using fractional exhaled nitric oxide (FeNO) as a biomarker of exposures to a range of air pollutants. This systematic review aims to summarize the studies that collected personal-level air pollution data to assess the air pollution-induced FeNO responses and to determine if utilizing personal-level data resulted in an improved characterization of the relationship between air pollution exposures and FeNO compared to using only ambient air pollution exposure data.
Recent Findings: Thirty-six eligible studies were identified. Overall, the studies included in this review establish that an increase in personal exposure to particulate and gaseous air pollutants can significantly increase FeNO. Nine out of the 12 studies reported statistically significant FeNO increases with increasing personal PM 2.5 exposures, and up to 11.5% increase in FeNO per IQR increase in exposure has also been reported between FeNO and exposure to gas-phase pollutants, such as ozone, NO 2, and benzene. Furthermore, factors such as chronic respiratory diseases, allergies, and medication use were found to be effect modifiers for air pollution-induced FeNO responses. About half of the studies that compared the effect estimates using both personal and ambient air pollution exposure methods reported that only personal exposure yielded significant associations with FeNO response. The evidence from the reviewed studies confirms that FeNO is a sensitive biomarker for air pollutant-induced airway inflammation. Personal air pollution exposure assessment is recommended to accurately assess the air pollution-induced FeNO responses. Furthermore, comprehensive adjustments for the potential confounding factors including the personal exposures of the co-pollutants, respiratory disease status, allergy status, and usage of medications for asthma and allergies are recommended while assessing the air pollution-induced FeNO responses.
(© 2024. The Author(s), under exclusive licence to Springer Nature Switzerland AG.)
References: Environ Sci Technol. 2018 Aug 7;52(15):8785-8791. (PMID: 29985591)
Environ Int. 2020 May;138:105647. (PMID: 32172043)
J Investig Allergol Clin Immunol. 2011;21(2):120-8. (PMID: 21462802)
Annu Rev Public Health. 1994;15:107-32. (PMID: 8054077)
Int J Environ Res Public Health. 2018 Nov 13;15(11):. (PMID: 30428575)
Occup Environ Med. 2015 Dec;72(12):830-6. (PMID: 26081623)
J Asthma Allergy. 2014 Apr 11;7:53-65. (PMID: 24748808)
J Expo Sci Environ Epidemiol. 2011 Jan-Feb;21(1):42-8. (PMID: 20588325)
Atmos Meas Tech. 2021 Feb;14(2):995-1013. (PMID: 35529304)
Clin Exp Allergy. 2011 Aug;41(8):1059-71. (PMID: 21623970)
J Allergy Clin Immunol. 2000 Oct;106(4):638-44. (PMID: 11031333)
Environ Health Perspect. 2003 Oct;111(13):1625-9. (PMID: 14527842)
J Expo Sci Environ Epidemiol. 2013 Nov-Dec;23(6):566-72. (PMID: 23632992)
PLoS One. 2019 Nov 1;14(11):e0224668. (PMID: 31675355)
Environ Health Perspect. 2016 Oct;124(10):1616-1622. (PMID: 27152705)
Environ Res. 2016 Oct;150:306-319. (PMID: 27336235)
Environ Health Perspect. 2006 Nov;114(11):1736-43. (PMID: 17107861)
Eur Respir J. 1999 Feb;13(2):301-6. (PMID: 10065672)
Environ Health. 2016 Sep 01;15(1):94. (PMID: 27586245)
Sci Total Environ. 2018 May 15;624:1539-1549. (PMID: 29929263)
Environ Int. 2018 Aug;117:82-90. (PMID: 29729518)
Thorax. 2006 Sep;61(9):817-27. (PMID: 16936238)
Environ Health. 2021 Feb 11;20(1):12. (PMID: 33573660)
J Allergy Clin Immunol. 2003 Nov;112(5):883-92. (PMID: 14610474)
Environ Sci Technol. 2021 Aug 3;55(15):10589-10596. (PMID: 34297563)
Inflammopharmacology. 2007 Dec;15(6):252-9. (PMID: 18236016)
Am J Respir Crit Care Med. 2021 Nov 15;204(10):e97-e109. (PMID: 34779751)
Inhal Toxicol. 2008 Feb;20(4):423-33. (PMID: 18302050)
Environ Pollut. 2021 Feb 15;271:116329. (PMID: 33370612)
J Asthma. 2022 Oct;59(10):2039-2050. (PMID: 34550855)
Chest. 2021 Sep;160(3):814-830. (PMID: 33887242)
Environ Pollut. 2018 Apr;235:505-513. (PMID: 29324380)
Clin Epigenetics. 2017 Jun 2;9:61. (PMID: 28588744)
Allergol Int. 2012 Sep;61(3):365-72. (PMID: 22824979)
Am J Respir Crit Care Med. 2001 Oct 15;164(8 Pt 1):1376-81. (PMID: 11704581)
Environ Res. 2012 Oct;118:118-23. (PMID: 22776327)
Environ Res. 2020 Sep;188:109780. (PMID: 32554275)
Thorax. 2002 Jul;57(7):643-8. (PMID: 12096210)
Environ Res. 2022 Nov;214(Pt 1):113745. (PMID: 35779616)
Environ Res. 2019 Oct;177:108620. (PMID: 31400563)
Thorax. 2002 May;57(5):383-7. (PMID: 11978911)
Clin Exp Allergy. 2018 Jul;48(7):798-805. (PMID: 29526044)
Environ Health Perspect. 2021 Sep;129(9):97005. (PMID: 34495741)
Occup Environ Med. 2010 Feb;67(2):118-24. (PMID: 19773283)
Environ Health Perspect. 2005 Apr;113(4):499-503. (PMID: 15811822)
Sci Total Environ. 2018 Jul 1;628-629:1497-1507. (PMID: 30045568)
Environ Res. 2016 Nov;151:756-762. (PMID: 27694044)
Eur Respir J. 2003 Mar;21(3):433-8. (PMID: 12661997)
Sci Total Environ. 2019 Feb 1;649:620-628. (PMID: 30176473)
Lancet Planet Health. 2017 Sep;1(6):e210-e211. (PMID: 29851602)
Eur Respir J. 2013 Aug;42(2):304-13. (PMID: 23314899)
Ann Am Thorac Soc. 2019 Jul;16(7):923-927. (PMID: 30958965)
J Occup Environ Med. 2022 May 1;64(5):361-369. (PMID: 35019895)
Int J Hyg Environ Health. 2019 Jun;222(5):756-764. (PMID: 31103472)
Chemosphere. 2019 Mar;218:992-1001. (PMID: 30609505)
Environ Sci Pollut Res Int. 2021 Apr;28(16):19615-19628. (PMID: 33660184)
Sci Total Environ. 2014 Jan 15;468-469:903-7. (PMID: 24080417)
Environ Res. 2018 Jul;164:24-31. (PMID: 29462750)
Environ Pollut. 2020 Oct;265(Pt A):114833. (PMID: 32544661)
معلومات مُعتمدة: R00 ES029116 United States ES NIEHS NIH HHS; R00ES029116 United States ES NIEHS NIH HHS
فهرسة مساهمة: Keywords: Air pollution; Airway inflammation; Fractional exhaled nitric oxide; Personal exposure
المشرفين على المادة: 31C4KY9ESH (Nitric Oxide)
0 (Air Pollutants)
0 (Particulate Matter)
0 (Biomarkers)
تواريخ الأحداث: Date Created: 20240222 Date Completed: 20240509 Latest Revision: 20240629
رمز التحديث: 20240629
مُعرف محوري في PubMed: PMC11180488
DOI: 10.1007/s40572-024-00430-1
PMID: 38386269
قاعدة البيانات: MEDLINE
الوصف
تدمد:2196-5412
DOI:10.1007/s40572-024-00430-1